Hermetica Superfood Encyclopedia
The Short Answer
Nauclea latifolia contains indoloquinolizidine alkaloids, flavonoids, tannins, and phenolics that drive antiplasmodial, anti-inflammatory, antioxidant, and carbohydrate enzyme-inhibitory activities through multiple molecular pathways. Root extract n-hexane fractions achieved 91.32% chemosuppression of Plasmodium infection in controlled animal models, while ethanolic leaf extracts inhibited α-amylase with an IC₅₀ of 1.19 mg/mL, placing this plant among the most pharmacologically diverse in West African ethnomedicine.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordNauclea latifolia benefits
Pin Cushion Tree — botanical close-up
Health Benefits
**Antimalarial Activity**
Root extracts, particularly the n-hexane fraction, demonstrated 91.32% chemosuppression in early-infection animal models and significant curative antiplasmodial activity comparable to chloroquine, supporting the Hausa and West African traditional use for malaria and fever treatment.
**Antidiabetic Potential**
Ethanolic leaf extracts inhibit both α-glucosidase (IC₅₀ 4.20 mg/mL) and α-amylase (IC₅₀ 1.19 mg/mL) through uncompetitive and competitive mechanisms respectively, suggesting potential for postprandial blood glucose control.
**Anti-Inflammatory Effects**: Ethanolic leaf extracts achieved 70
54% inhibition of albumin denaturation and dose-dependent suppression of hypotonic- and heat-induced erythrocyte haemolysis, indicating membrane-stabilizing and protein-protective anti-inflammatory properties.
**Antioxidant Defense**
Leaf extracts demonstrate measurable total antioxidant capacity, reducing power, and radical scavenging activity against DPPH and hydrogen peroxide free radicals, effects attributed to the combined action of flavonoids, tannins, and phenolic acids.
**Nutritional Micronutrient Contribution**
Root and stem bark contain notably high concentrations of fat-soluble and water-soluble antioxidant vitamins, including Vitamin A (89–103 mg/100g), Vitamin C (45–75 mg/100g), and Vitamin E (75–106 mg/100g), which may complement its pharmacological antioxidant activity.
**Gastrointestinal and Antimicrobial Support**
Ethnomedicinal records document widespread use for dysentery, diarrhea, gastric ulcer, and gonorrhea, consistent with the demonstrated antimicrobial alkaloid content, though direct mechanistic data for these applications remain limited to preliminary phytochemical attribution.
**Fever and Analgesic Properties**
Traditional use for fever, pain, and typhoid fever across multiple West African ethnic groups is supported by the plant's anti-inflammatory and antiplasmodial mechanisms, with alkaloids and flavonoids proposed as the primary bioactive drivers of antipyretic and analgesic effects.
Origin & History
Natural habitat
Nauclea latifolia is a tropical tree native to sub-Saharan Africa and parts of Asia, distributed widely across West Africa including Nigeria, Ghana, Senegal, and Cameroon, as well as Central and East African forest margins. It thrives in humid tropical lowlands, riverine forests, and forest edges at low to moderate altitudes, typically in well-drained lateritic or sandy loam soils with high rainfall. The tree is not formally cultivated as a crop but is harvested from wild populations by local communities for both medicinal and limited timber use.
“Nauclea latifolia has been integral to the traditional medicine systems of the Hausa, Yoruba, Igbo, and numerous other West and Central African peoples for centuries, where it is among the most commonly cited plants for malaria, fever, and a broad spectrum of infectious and metabolic diseases. The tree's common name 'pin cushion tree' derives from the distinctive spherical, pin-cushion-like inflorescences of small tubular flowers, which are also used as a cultural identifier across its range. Traditional healers prepare decoctions and infusions from the root bark, stem bark, and leaves depending on the condition being treated, with root bark preparations most frequently associated with antimalarial and antipyretic applications. The plant holds particular prominence in Nigerian ethnomedicine, where comprehensive ethnobotanical surveys have documented its use for over two dozen distinct disease conditions, reflecting its status as a high-priority plant for pharmacological investigation in African drug discovery programs.”Traditional Medicine
Scientific Research
The current body of evidence for Nauclea latifolia consists almost entirely of in vitro laboratory assays and controlled animal model experiments, with no published randomized controlled trials in human subjects identified in the available literature. The most rigorous pharmacological data come from quantified enzyme inhibition studies of leaf extracts (with defined IC₅₀ values) and antiplasmodial suppression studies using rodent malaria models, where n-hexane root fractions achieved 91.32% chemosuppression with reductions in parasitaemia detectable from day 2 of treatment. Phytochemical and antioxidant studies have used standardized radical scavenging assays (DPPH, hydrogen peroxide) with appropriate comparator compounds, lending some methodological credibility to these in vitro findings. The absence of phase I safety trials, pharmacokinetic data, and human efficacy studies represents a significant evidentiary gap that prevents any firm therapeutic conclusions from being drawn for human applications.
Preparation & Dosage
Traditional preparation
**Traditional Decoction (Root Bark)**
Roots and stem bark are decocted in water and consumed orally for malaria, fever, and gastrointestinal complaints; no standardized volume or concentration is documented in the formal literature.
**Aqueous Leaf Extract (Research)**
20 mg/mL to characterize enzyme inhibition and antioxidant activity; no human-equivalent dose has been established
Used in laboratory studies at concentrations ranging from 0.5 to .
**Ethanolic Leaf Extract (Research)**
19 mg/mL — no clinical dosage equivalent available
Prepared by maceration in ethanol; demonstrates superior phytochemical yield and potency compared to aqueous extraction, with α-amylase IC₅₀ of 1..
**Root Fractionated Extracts (Research)**
Sequential fractionation using n-hexane, ethyl acetate, and butanol solvents has been used to isolate antiplasmodial fractions in animal studies; not available as standardized commercial supplements.
**Standardization Status**
No commercially standardized extract (e.g., defined alkaloid or flavonoid percentage) has been reported in available literature; all dosage information derives from ethnobotanical practice or research laboratory protocols.
**Timing Notes**
Traditional use is typically administered multiple times daily during active fever or malarial episodes; no evidence-based timing recommendations can be provided.
Nutritional Profile
Root and stem bark of Nauclea latifolia contain unusually high concentrations of antioxidant vitamins relative to typical herbal materials: Vitamin A ranges from 89.33 to 103.18 mg/100g dry weight, Vitamin E from 74.80 to 106.25 mg/100g, and Vitamin C from 45.14 to 74.80 mg/100g, though the bioavailability of these vitamins from bark decoctions has not been formally assessed. Riboflavin and niacin are present in trace amounts in bark preparations. Phytochemically, the plant is rich in indoloquinolizidine alkaloids (the dominant class across all plant parts), flavonoids (appreciable concentrations in root and stem bark), tannins (trace amounts in bark), phenolic acids, terpenoids, cardiac glycosides, quinones, and saponins. Ethanolic leaf extracts contain significantly higher total phytochemical content than aqueous extracts, suggesting that solvent polarity substantially affects the extractable nutritional and bioactive profile. No macronutrient (protein, fat, carbohydrate) compositional data are available in the current literature.
How It Works
Mechanism of Action
The indoloquinolizidine alkaloids that dominate the phytochemical profile of Nauclea latifolia are the primary drivers of antiplasmodial activity, likely disrupting heme detoxification in Plasmodium falciparum in a manner analogous to quinoline-class antimalarials, while also exhibiting broad membrane-disrupting effects on microbial pathogens. Flavonoids and phenolic compounds inhibit carbohydrate-metabolizing enzymes α-amylase and α-glucosidase through competitive and uncompetitive binding respectively, reducing the rate of complex carbohydrate hydrolysis and consequent glucose absorption in the intestinal lumen. Anti-inflammatory activity is mediated through inhibition of protein denaturation and stabilization of erythrocyte membranes against hypotonic and thermal stress, mechanisms that parallel the prostaglandin-independent pathways of membrane-active NSAIDs, although potency remains lower than reference drugs such as ibuprofen at equivalent doses. The significant positive correlation between antioxidant activity and carbohydrate enzyme inhibition observed in leaf extracts suggests that free radical scavenging by phenolic compounds may protect the active enzyme-binding conformation of these inhibitory molecules, amplifying their combined metabolic effect.
Clinical Evidence
No human clinical trials investigating Nauclea latifolia as a therapeutic intervention have been identified in the current literature, which limits the clinical summary to a characterization of preclinical evidence. Animal model studies demonstrated antiplasmodial suppression exceeding 90% with root fractions and curative activity comparable to chloroquine, though extrapolation to human dose-response relationships is not possible without pharmacokinetic bridging studies. In vitro antidiabetic assays yielded quantified IC₅₀ values for enzyme inhibition but these concentrations have not been validated against achievable plasma levels following oral administration. Overall confidence in clinical efficacy for any indication must be classified as low-to-preliminary, with the ethnomedicinal record providing the strongest contextual support for continued formal clinical investigation, particularly for malaria, fever, and glycemic management.
Safety & Interactions
Comprehensive safety data for Nauclea latifolia in humans are absent from the current published literature, and no formal toxicology studies, maximum tolerated dose determinations, or adverse event reporting from clinical use are available. The presence of cardiac glycosides in the phytochemical profile warrants caution, as this compound class can affect cardiac conduction and may interact with antiarrhythmic drugs, digoxin, and other cardiac medications; however, the concentration and bioavailability of these glycosides from traditional preparations have not been quantified. Anti-inflammatory extracts showed weaker haemolysis inhibition than ibuprofen at equivalent doses, suggesting the plant's bioactive potency may limit acute toxicity risk, but this observation does not constitute safety clearance. Pregnancy, lactation, pediatric use, and interactions with antimalarial drugs such as artemisinin-based combination therapies or chloroquine should be regarded as unstudied contraindications until formal safety trials are conducted.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Nauclea latifoliaAfrican peachEgbesi (Yoruba)Tafashiya (Hausa)Ubukiribu (Igbo)
Frequently Asked Questions
What is Nauclea latifolia used for in traditional medicine?
Nauclea latifolia is used across West and Central Africa to treat malaria, fever, diabetes, hypertension, dysentery, gastric ulcers, gonorrhea, respiratory ailments, and over two dozen other conditions. The root bark and stem bark are most commonly prepared as decoctions for antimalarial and antipyretic purposes, while leaf preparations are associated with anti-inflammatory and gastrointestinal uses. Its breadth of ethnomedicinal application makes it one of the most widely used medicinal trees in the African pharmacopoeia.
Does Nauclea latifolia have proven antimalarial activity?
Preclinical animal studies have demonstrated that the n-hexane fraction of Nauclea latifolia root extract achieves 91.32% chemosuppression of Plasmodium infection, with curative activity comparable to chloroquine and observable reductions in parasitaemia beginning from day 2 of treatment. These results are promising and consistent with the plant's traditional use, but no human clinical trials have been conducted, so definitive proof of antimalarial efficacy in humans cannot be established from current evidence. The indoloquinolizidine alkaloids are the primary compounds believed to drive this activity.
Can Pin Cushion Tree help with blood sugar control?
Ethanolic leaf extracts of Nauclea latifolia inhibit two key carbohydrate-digesting enzymes — α-glucosidase (IC₅₀ 4.20 mg/mL) and α-amylase (IC₅₀ 1.19 mg/mL) — through competitive and uncompetitive mechanisms respectively, which would theoretically slow glucose absorption after meals. However, these are in vitro laboratory values and have not been tested in human subjects, so no clinical dosage recommendation for blood sugar management can be made. Flavonoids and phenolic compounds in the leaf extract are the primary candidates responsible for enzyme inhibition.
Is Nauclea latifolia safe to use as a supplement?
Formal human safety data, toxicology studies, and clinical adverse event reporting for Nauclea latifolia are absent from the published scientific literature, making a definitive safety assessment impossible at this time. The plant contains cardiac glycosides, which can interact with heart medications and affect cardiac rhythm at high doses, warranting caution. Pregnant and breastfeeding individuals, people on antimalarial drugs, and those with cardiac conditions should avoid use until formal safety studies are completed.
What are the main bioactive compounds in Pin Cushion Tree?
The dominant bioactive compounds in Nauclea latifolia are indoloquinolizidine alkaloids, which are responsible for the plant's antiplasmodial and antimicrobial properties. The plant also contains significant quantities of flavonoids, tannins, phenolic acids, terpenoids, saponins, quinones, and cardiac glycosides distributed across its leaves, root bark, and stem bark. Root and stem bark are also notable for unusually high concentrations of Vitamins A (89–103 mg/100g), C (45–75 mg/100g), and E (75–106 mg/100g).
What is the difference between Pin Cushion Tree root and leaf extracts?
Pin Cushion Tree roots and leaves contain different bioactive profiles optimized for different therapeutic applications. Root extracts, particularly the n-hexane fraction, demonstrate superior antimalarial activity with 91.32% chemosuppression comparable to chloroquine, while ethanolic leaf extracts are more effective for antidiabetic activity through α-glucosidase inhibition. The choice between forms depends on whether the primary health goal is malaria/fever management or blood sugar support.
Who should avoid Pin Cushion Tree supplementation?
Pregnant and nursing women should avoid Pin Cushion Tree supplementation due to insufficient safety data in these populations, and its traditional use as an antimalarial suggests potential uterine activity. Individuals taking antimalarial medications like chloroquine or artemisinin-based therapies should consult a healthcare provider before use, as concurrent supplementation may create unexpected interactions or redundant effects. People with severe liver or kidney impairment should exercise caution since extract processing and metabolism may be compromised.
How strong is the clinical evidence for Pin Cushion Tree's effectiveness?
The evidence for Pin Cushion Tree is primarily based on in vitro studies and animal models, with the most compelling data showing root extracts achieving 91.32% chemosuppression in early-infection animal models—matching chloroquine efficacy. However, robust human clinical trials are limited, meaning traditional use in West African and Hausa medicine provides historical support but cannot replace gold-standard RCT evidence for efficacy claims. The antidiabetic evidence relies mainly on enzymatic inhibition studies rather than human glucose tolerance trials, indicating this ingredient needs translational research before strong recommendations can be made.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w pin-cushion-tree-nauclea-latifolia curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
